T0	Limitation 28201 28206	Lyden
T1	Limitation 28420 28423	The
T2	Limitation 29253 29256	The
T3	Limitation 29710 29713	The
T4	Limitation 29879 29887	However,
T5	Limitation 31316 31321	Lyden
T6	Limitation 32129 32132	Our
T7	UnderpoweredStudy 28262 28330	IST-3 recruited only half the number of patients originally intended
T8	CompositeIntervention 28420 28598	The many changes in the regulatory environment over the course of the trial delayed the approval of the trial in many centres and precluded the participation of several countries
#1	AnnotatorNotes T8	Regulation
T10	ReliabilityOfMeasurement 29888 29947	self-reported outcome by patients is necessarily subjective
T11	ReliabilityOfMeasurement 29714 29877	self-assessment at 6 months by patients or their carer by postal questionnaire or masked telephone interview was unmasked and so could be subject to reporting bias
T12	OTHER 29253 29339	The absence of masking is most relevant for the assessment of the events within 7 days
T13	SampleSize 31341 31434	the sampling approach to monitoring in IST-3 was less intense than in many commercial studies
T9	UnderpoweredStudy 32143 32201	underpowered to reliably detect important subgroup effects
